Table 2 Clinicopathologic characteristics of patients and hepatic observations
Characteristic | Value (%) |
|---|---|
Patient (n = 379) | |
 Mean age (years)a | 58.1 ± 10.4 |
 Sex, male/female | 265/114 |
 Cirrhosis (%) | 314 (82.8%) |
Cause of liver disease (%) | |
 Hepatitis B virus | 301 (79.4) |
 Hepatitis C virus | 38 (10.0) |
 Alcohol consumption | 9 (2.4) |
 Autoimmune disorders | 4 (1.1) |
 NASH | 1 (0.3) |
 Hepatitis B and C virus | 6 (1.6) |
 Cirrhosis of unknown cause | 20 (5.3) |
Number of observations per patient (%) | |
 1 | 341 (90.0) |
 2 | 29 (7.7) |
 3 | 9 (2.4) |
Observation (n = 426) | |
 Size (mm) | |
  Over allb | 27 (16–52) |
  HCCa | 34.7 ± 27.3 |
  Non-HCC malignancyb | 45 (27–66) |
  Benign lesionb | 22 (14–44) |
 Final diagnosis (%) | |
  HCC | 250 (58.7) |
  Non-HCC malignancy | 88 (20.7) |
  ICC | 41 (9.6) |
  CHC | 13 (3.1) |
  Metastasis | 23 (5.4) |
  Sarcomatoid carcinoma | 6 (1.4) |
  Cystadenocarcinoma | 3 (0.7) |
  Neuroendocrine carcinoma | 1 (0.2) |
  Haemangiosarcoma | 1 (0.2) |
  Benign lesion | 88 (20.7) |
  Haemangioma | 16 (3.8) |
  DN | 34 (8.0) |
  RN | 11 (2.6) |
  FNH | 9 (2.1) |
  Adenoma or adenomatoid hyperplasia | 6 (1.4) |
  Abscess | 4 (0.9) |
  Angiomyolipoma | 2 (0.5) |
  Epithelioid angiomyolipoma | 3 (0.7) |
  Inflammatory nodule | 1 (0.2) |
  Lipomyoma | 1(0.2) |
  Ematoma | 1 (0.2) |
Standard reference of diagnosis (%) | |
  Surgical pathology | 199 (46.7) |
  Biopsy pathology | 227 (53.3) |